Kyowa Kirin (OTCMKTS:KYKOF) Stock Price Down 9.3% – Time to Sell?

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was down 9.3% during trading on Monday . The company traded as low as $15.05 and last traded at $15.05. Approximately 12,492 shares were traded during trading, an increase of 1,685% from the average daily volume of 700 shares. The stock had previously closed at $16.59.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group downgraded shares of Kyowa Kirin to a “sell” rating in a report on Tuesday, December 16th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

Kyowa Kirin Stock Down 9.3%

The firm’s fifty day moving average is $15.76 and its 200 day moving average is $16.27.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. is a global biopharmaceutical company headquartered in Tokyo, Japan, specializing in the research, development and commercialization of innovative therapies. Established through the merger of Kyowa Hakko Kogyo Co, Ltd. and Kirin Pharma Co, Ltd. in 2008, the company operates as part of the Kirin Group and pursues a mission of delivering cutting-edge medicines in areas of high unmet medical need. Its corporate structure supports integrated research and development, manufacturing and worldwide licensing activities.

The company’s therapeutic focus spans oncology, nephrology, immunology and central nervous system disorders.